Dutch Ministry Of Health Will Not Reimburse Gilead’s Breast Cancer Drug, Trodelvy Last month, the Dutch Ministry of Health, Welfare and Sport (VWS) announced that it will not include the breast cancer drug Trodelvy (sacituzumab govitecan-hziy) in the country’s standard package of pharmacy and medical benefits.